Acute severe asthma: New approaches to assessment and treatment

Drugs

Volumn 69, Issue 17, 2009, Pages 2363-2391

  Papiris, Spyros A ^a   Manali, Effrosyni D ^a   Kolilekas, Likurgos ^a   Triantafillidou, Christina ^a   Tsangaris, Iraklis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; CISATRACURIUM; CORTICOSTEROID; DEXMEDETOMIDINE; ETILEFRINE; FENOTEROL; FENTANYL; FLUNISOLIDE; FLUTICASONE PROPIONATE; HELIOX; HYDROCORTISONE; IPRATROPIUM BROMIDE; ISOPRENALINE; KETAMINE; LEVALBUTEROL; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PIRBUTEROL; PREDNISONE; PROPOFOL; REMIFENTANIL; REPROTEROL; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; UNINDEXED DRUG; ZAFIRLUKAST;

ACIDITY; ADD ON THERAPY; AMNESIA; ANALGESIA; APNEA; ARTERIAL CARBON DIOXIDE TENSION; ARTIFICIAL VENTILATION; ASTHMA; BRAIN EDEMA; BRONCHODILATATION; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMA; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG MEGADOSE; EXPIRATORY FLOW; FATIGUE; FLUSHING; GAS EXCHANGE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPERCAPNIA; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPOXEMIA; INTRACRANIAL HYPERTENSION; INTUBATION; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG MECHANICS; MENTAL HEALTH; METABOLIC ALKALOSIS; METERED DOSE INHALER; MOOD DISORDER; NEBULIZER; OXYGEN CONSUMPTION; OXYGEN THERAPY; PAIN; PATHOPHYSIOLOGY; PATIENT SAFETY; PERIPHERAL EDEMA; POSITIVE END EXPIRATORY PRESSURE; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT INDICATION; TREATMENT RESPONSE; VENTILATOR; VOMITING;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CONSCIOUS SEDATION; DRUG THERAPY, COMBINATION; HUMANS; IPRATROPIUM; NEBULIZERS AND VAPORIZERS; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY; STATUS ASTHMATICUS;

EID: 72049132604     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11319930-000000000-00000     Document Type: Review

References (170)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention, updated 2008 [online]. Available from URL: http://www.ginasthma.org [Accessed 2009 Oct 1]
2. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008; 63 Suppl. 4: iv1-121
3. US Department of Health and Human Services. National Asthma Education and Prevention Program. Expert Panel report 3: guidelines for the diagnosis and management of asthma. Summary report 2007. NIH Publication no.: 08-5846 [online]. Available from URL: http://www.nhlbi. nih.gov/guidelines/asthma/ asthsumm.pdf [Accessed 2009 Aug 27]
4. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9 Fanta CH. Asthma. N Engl J Med 2009; 360: 1002-14
5. Tillie-Leblond I, Gosset P, Tonnell A-B. Inflammatory events in severe acute asthma. Allergy 2005; 60: 23-29
6. Carroll N, Carello S, Cooke C, et al. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996; 9: 709-715
7. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989; 140: 5-9
8. Papiris S, Kotanidou A, Malagari K, et al. Clinical review: severe asthma. Crit Care 2002; 6: 30-44
9. McFadden Jr ER. Acute severe asthma. Am J Respir Crit Care Med 2003; 168: 740-759
10. Roe PF. Sudden death in asthma. Br J Dis Chest 1965; 59: 158-63 Benatar SR. Fatal asthma. N Engl J Med 1986; 314: 423-9
11. McFadden Jr ER. Fatal and near-fatal asthma. N Engl J Med 1991; 324: 409-411
12. McFadden Jr ER, Warren EL. Observations on asthma mortality. Ann Intern Med 1997; 127: 142-147
13. Masoli M, Fabian D, Holt S, et al. GINA program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59 (5): 469-478
14. Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330: 1329-1334
15. Scoggin CH, Sahn SA, Petty TL. Status asthmaticus: a nine year experience. JAMA 1977; 238: 1158-1162
16. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125: 1081-1102
17. Rodrigo C. Acute severe asthma: management in the emergency department and in the intensive care unit [in Spanish]. Med Intensiva 2006; 30: 460-470
18. Picado C. Classification of severe asthma exacerbations: a proposal. Eur Respir J 1996; 9: 1775-1778
19. Werner HA. Status asthmaticus in children. Chest 2001; 119: 1913-1929
20. Molfino NA, Nannini LJ, Martelli AN, et al. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324: 285-288
21. Molfino NA, Slutsky AS. Near fatal asthma. Eur Respir J 1994; 7: 981-990
22. Dhuper S, Maggiore D, Chung V, et al. Profile of near-fatal asthma in an inner-city hospital. Chest 2003; 124: 1880-1884
23. Romagnoli M, Caramori G, Braccioni F, et al.; and the ENFUMOSA Study Group. Near-fatal asthma pheno-type in the ENFUMOSA Cohort. Clin Exp Allergy 2007; 37: 552-557
24. Sidebotham HJ, Roche WR. Asthma deaths: persistent and preventable mortality. Histopathology 2003; 43: 105-117
25. Warren EL, McFadden Jr ER. Sudden death in asthma. In: Barnes PJ, Grunstein MM, Leff AR, et al., editors. Asthma. Philadelphia (PA): Lippincott-Raven, 1997: 1945-1954
26. Wasserfallen J-B, Schaller M-D, Feihl F, et al. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990; 142: 108-111
27. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 1993; 148: 713-719
28. Reid LM. The presence or absence of bronchial mucus in fatal asthma. J Allergy Clin Immunol 1987; 80: 415-416
29. Lai CKW, Beasley R, Crane J, et al. Global variation in the prevalence of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476-483
30. Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006; 174: 633-638
31. Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 2008; 122: 662-668
32. Pendergraft TB, Stanford RH, Beasley R, et al. Rates and characteristics of intensive care unit admissions and intubations among asthma related hospitalizations. Ann Allergy Asthma Immunol 2004; 93: 29-35
33. Elsayegh D, Saito S, Eden E, et al. Increasing severity of status asthmaticus in an urban medical intensive care unit. J Hosp Med 2008; 3: 206-211
34. Kuehni CE, Davis A, Brooke AM, et al. Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet 2001; 357: 1821-1825
35. Pearce N, Aot-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758-766
36. Wijesinghe M, Weatherall M, Perrin K, et al. International trends in asthma mortality rates in the 5-to 34-year age group: a call for closer surveillance. Chest 2009; 135: 1045-1049
37. Lopez-Campos JL, Cayuela A, Rodriguez-Dominguez S, et al. Temporal trends in asthma mortality over 30 years. J Asthma 2008; 45: 611-614
38. Turner MO, Noertjojo K, Vedal S, et al. Risk factors for near fatal asthma: a case control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998; 157: 1804-1809
39. Marquette CH, Saulnier F, LeRoy O, et al. Long term prognosis in near fatal asthma. Am Rev Respir Dis 1992; 146: 76-81
40. Pedersen B, Dahl R, Kalstrom R, et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled bunesonide: the impact of smoking. Am J Respir Crit Care Med 1996; 153: 1519-1529
41. Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997; 10: 1359-1371
42. Rodriguez-Roisin R, Ballaster E, Roca J, et al. Mechanism of hypoxemia in patients with status asthmaticus requiring mechanical ventilation. Am Rev Respir Dis 1989; 139: 732-739
43. Mountain RD, Heffner JE, Brackett NC, et al. Acid base disturbances in acute asthma. Chest 1990; 98: 651-655
44. Corbridge TC, Hall JB. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995; 151: 1296-1316
45. Stratakos G, Kalomenidis I, Routsi C, et al. Transient lactic acidosis as a side effect of inhaled salbutamol. Chest 2002; 122: 385-386
46. Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 1982; 307: 786-797
47. Roussos CS, Macklem PT. Diaphragmatic fatigue in man. J Appl Physiol 1977; 43: 189-197
48. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998; 24: 105-117
49. Manthous CA. Management of severe exacerbations of asthma. Am J Med 1995; 99: 298-308
50. Moy ML, Lantin ML, Harver A. Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol. Am J Respir Crit Care Med 1998; 158: 749-753
51. Restrepo RD, Peters J. Near-fatal asthma: recognition and management. Curr Opin Pulm Med 2008; 14: 13-23
52. Appel D, Rubenstein R, Kenneth S. Lactic acidosis in severe asthma. Am J Med 1983; 75: 580-584
53. Grossman J. The occurrence of arrhythmias in hospitalized asthma patients. J Allergy Clin Immunol 1976; 57: 310-317
54. White CS, Cole RP, Lubetsky HW, et al. Acute asthma: admission chest radiography in hospitalized adult patients. Chest 1991; 100: 14-16
55. Pickup CM, Nee PA, Randall PE. Radiographic features in 1016 adults admitted to hospital with acute asthma. J Accid Emerg Med 1994; 11: 234-237
56. Silverman RA, Flaster E, Enright PL, et al. FEV1 performance among patients with acute asthma: results from a multicenter clinical trial. Chest 2007; 131: 164-171
57. Lemarchand P, Labrune S, Herer B, et al. Cardiorespiratory arrest following peak expiratory flow measurement during attack of asthma. Chest 1991; 100: 1168-1169
58. Ballester E, Reyes A, Roca J, et al. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989; 44: 258-267
59. Chien JW, Ciufo R, Novak R, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000; 117: 728-733
60. Lin RY, Sauter D, Newman T, et al. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993; 22: 1847-1853
61. Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albu-terol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993; 22: 1842-1846
62. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21: 1479-1486
63. Cairns CB. Acute asthma exacerbations: phenotypes and management. Clin Chest Med 2006; 27: 99-108
64. Travers A, Jones AP, Kelly K, et al. Intravenous beta 2 agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; (1): CD002988
65. Page CP, Morley J. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol 1999; 104 (2 Pt 2): S31-41
66. Dhand R, Goode M, Reid R, et al. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic al-buterol. Am J Respir Crit Care Med 1999; 160: 1136-1141
67. Nowak R. Single-isomer levalbuterol: a review of the acute data. Curr Allergy Asthma Rep 2003; 3: 172-178
68. Nelson H, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared to racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102: 943-952
69. McFadden Jr ER, Strauss L, Hejal R, et al. Comparison of two dosage regimens of albuterol in acute asthma. Am J Med 1998; 105: 12-17
70. Siwik JP, Nowak RM, Zoratti EM. The evaluation and management of acute severe asthma. Med Clin N Am 2002; 86: 1049-1071
71. Wiebe K, Rowe BH. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. Can J Emerg Med 2007; 9 (4): 304-308
72. Grundstom N, Anderson RGG, Wikberg JES. Prejunctional alpha 2-adrenaline receptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic transmission. Life Sci 1981; 28: 2981-2986
73. Coupe MO, Guly U, Brown E, et al. Nebulized adrenaline in acute severe asthma, comparison with salbutamol. Eur J Respir Dis 1987; 71: 227-232
74. Peters JI, Rossrucker J. Current concepts in managing status asthmaticus. J Respir Dis 1992; 13: 829-849
75. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma. Am J Respir Crit Care Med 2001; 163: 32-36
76. Sherman MS, Verceles AC, Lang D. Systemic steroids for the treatment of acute asthma: where do we stand? Clin Pulm Med 2006; 13: 315-320
77. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001; (1): CD002178
78. Alvarez J, Surs W, Leung DY, et al. Steroid resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992; 89: 714-721
79. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998; 157: 698-703
80. Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005; 171 (11): 1231-1236
81. Edmonds ML, Camargo CA, Pollack CV, et al. Early use of inhaled corticosteroids in the emergency department of acute asthma. Cochrane Database Syst Rev 2003; (3): CD002308
82. Volovitz B, Bentur L, Finkelstein Y, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998; 102: 605-609
83. McFadden Jr ER. Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect? Am J Respir Crit Care Med 1998; 157: 677-678
84. Cairns CB, Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med 1996; 3: 1093-1097
85. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulphate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; (2): CD001490
86. Rowe BH, Camargo Jr CA, for the Multicenter Airway Research Collaboration (MARC) Investigators. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol 2006; 117: 53-58
87. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulphate in the treatment of acute asthma. Cochrane Database Syst Rev 2005; (4): CD003898
88. Rowe BH, Camargo Jr CA. The role of magnesium sulphate in the acute and chronic management of asthma. Curr Opin Pulm Med 2008; 14: 70-76
89. Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 1984; 129: 856-870
90. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment. Chest 2002; 121: 1977-1987
91. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740-746
92. Rodrigo GJ, Rodrigo C. Triple inhaled drug protocol for the treatment of acute severe asthma. Chest 2003; 123: 1908-1915 (Pubitemid 36706711)
93. Higbee MD, Kumar M, Galant SP. Stimulation of endogenous catecholamine release by theophylline: a proposed additional mechanism of action for theophylline effects. J Allergy Clin Immunol 1982; 70: 377-382
94. Mackay AD, Baldwin CJ, Tattersfield AE. Action of intravenously administered aminophylline on normal airways. Am Rev Respir Dis 1983; 127: 609-613
95. Pretzlaff RK, Vardis RJ, Pollack MM. Aminophylline in the treatment of fluid overload. Crit Care Med 1999; 27: 2782-2785
96. Aubier M, De Troyer A, Sampson M, et al. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305: 249-252
97. Miech RP, Niedzwicki JD, Smith TR. Effect of theophylline on the binding of cAMP to soluble protein from tracheal smooth muscle. Biochem Pharmacol 1979; 28: 3687-3688
98. Horrobin DF, Manku MS, Frank DJ, et al. Methylxanthine phosphodiesterase inhibitors behave as prosta-glandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins 1977; 13: 33-40
99. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; (4): CD002742
100. Dahlen SE. Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur J Pharmacol 2006; 533: 40-56
101. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 2005; 127: 1312-1326
102. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006; 36: 689-703
103. Holgate ST, Peters-Golden M, Panettieri RA, et al. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003; 111 (1 Suppl.): S18-34
104. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206
105. Currie GP, Srivastava P, Dempsey OJ, et al. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists. Q J Med 2005; 98: 171-182
106. Taylor GW, Taylor I, Black P, et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989; 1: 584-588
107. Carmargo CA, Smithline HA, Malice MP, et al. A randomised controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167: 528-533
108. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000; 55: 260-265
109. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomised, double-blind, multicenter trial. Chest 2004; 126: 1480-1489
110. Polosa R. Critical appraisal of antileukotriene use in asthma management. Curr Opin Pulm Med 2007; 13: 24-30
111. Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest 1995; 107: 757-760
112. Gluck EH, Onorato DJ, Castriotta RJ. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98: 693-698
113. Manthous CA, Hall JB, Melmed A, et al. Heliox improves pulsus paradodoxus and peak expiratory flow in non-intubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151: 310-314
114. Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during treatment of status asthmaticus in children. J Pediatr 1997; 130: 217-224
115. Anderson M, Svantergren M, Bylin G, et al. Deposition in asthmatics of particles inhaled in air or in heliumoxygen. Am Rev Respir Dis 1993; 147: 524-528
116. Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; (4): CD002884
117. Hess DR, Acosta FL, Ritz RH, et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999; 115: 184-189
118. Hess D, Chatmongkolchart S. Techniques to avoid intubation: noninvasive positive pressure ventilation and heliox therapy. Int Anesthesiol Clin 2000; 38: 161-187
119. Carroll CL, Smith SR, Collins MS, et al. Endotracheal intubation and pediatric status asthmaticus: site of original care affects treatment. Pediatr Crit Care Med 2007; 8: 91-95
120. Papiris SA, Roussos C. Pleural disease in the intensive care unit. In: Bouros D, editor. Pleural disease. New York: Marcel Dekker, Inc., 2004: 757-782
121. Zimmerman JL, Dellinger RP, Shah AN, et al. Endotracheal intubation and mechanical ventilation in severe asthma. Crit Care Med 1993; 21: 1727-1730
122. Bellomo R, McLaughlin P, Tai E, et al. Asthma requiring mechanical ventilation: a low morbidity approach. Chest 1994; 105: 891-896
123. Conti J, Ferretti A, Tellan G, et al. Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus. Intensive Care Med 1993; 19: 305
124. Hashiba E, Hirota K, Suzuki K, et al. Effects of propofol on bronchoconstriction and bradycardia induced by vagal nerve stimulation. Acta Anaesthesiol Scand 2003; 47: 1059-1063
125. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005; 46: 43-50
126. Takasaki Y, Kido T, Semba K. Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma. J Anesth 2009; 23: 147-150
127. Behbehani NA, Al-Mane F, Dyachkova Y, et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 1999; 115: 1627-1631
128. Adnet F, Dhissi G, Borron SW, et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 2001; 27: 1729-1736
129. Kesler S, Sprenkle M, David W, et al. Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis. Intensive Care Med 2009; 35: 157-160
130. Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994; 150: 1722-1737
131. Galluccio ST, Rai S, Sharley P. An unexpected ending: brain death following acute severe asthma. Crit Care Resusc 2008; 10: 235-238
132. Carroll CL, Zucker AR. Barotrauma not related to type of positive pressure ventilation during severe asthma exacerbations in children. J Asthma 2008; (5): 421-424
133. Slutsky AS. Mechanical ventilation. Chest 1993; 104: 1833-1859
134. Georgopoulos D, Kondili E, Prinianakis G. How to set the ventilator in asthma. Monaldi Arch Chest Dis 2000; 55: 74-83
135. Patroniti N, Saini M, Zanella A, et al. Measurement of end-expiratory lung volume by oxygen washing-washout in controlled and assisted mechanically ventilated patients. Intensive Care Med 2008; 34: 2235-2240
136. Olegard C, Sondergaard S, Houltz E, et al. Estimation of functional residual capacity at the bedside using standard monitoring equipment: a modified nitrogen washout/ washin technique requiring a small change of the inspired oxygen fraction. Anesth Analg 2005; 101: 206-212
137. Tuxen DV, Williams TJ, Scheinkestel CD, et al. Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. Am Rev Respir Dis 1992; 146: 1136-1142
138. Leatherman JW, McArthur C, Shapiro RS. Effect of prolongation of expiratory time on dynamic hyperinflation in mechanically ventilated patients with severe asthma. Crit Care Med 2004; 32: 1542-1545
139. Fink JB, Dhand R, Duarte AG, et al. Deposition of aerosol from metered-dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med 1996; 154: 382-387
140. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997; 156: 3-10
141. Jones A, Rowe B, Peters J, et al. Inhaled beta-agonists for asthma in mechanically ventilated patients. Cochrane Database Syst Rev 2001; (4): CD001493
142. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113: 593-598
143. Goode ML, Fink JB, Dhand R, et al. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001; 163: 109-114
144. Tassaux D, Jolliet P, Thouret JM, et al. Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med 1999; 160: 22-32
145. Oppenheim-Eden A, Cohen Y, Weissman C, et al. The effect of helium on ventilator performance: study of five ventilators and a bedside Pitot tube spirometer. Chest 2001; 120: 582-588
146. Bogie AL, Towne D, Luckett PM, et al. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007; 23: 355-361
147. Cydulka R, Davison R, Grammer L, et al. The use of epinephrine in the treatment of older adult asthmatics. Ann Emerg Med 1988; 17: 322-326
148. Lenchner KI, Saltoun C. Status asthmaticus. Allergy Asthma Proc 2004; 25 (4 Suppl. 1): S31-3
149. Haskell RJ, Wong BM, Hansen JE. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med 1983; 143: 1324-1327
150. Marquette CH, Stach B, Cardot E, et al. High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J 1995; 8: 22-27
151. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2001; (1): CD001740
152. Sydow M, Crozier TA, Zielmann S, et al. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 1993; 19: 467-471
153. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995; 107: 1576-1581
154. American Thoracic Society, European Respiratory Society, the European Society of Intensive Care Medicine, and the Societe de Reanimation de Langue Française. International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 2001; 163: 283-291
155. Chevrolet JC, Jollet P, Abajo B, et al. Nasal positive pressure ventilation in patients with acute respiratory failure: difficult and time-consuming procedure for nurses. Chest 1991; 100: 775-782
156. Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996; 110: 767-774
157. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003; 123: 1018-1025
158. Ram FS, Wellington S, Rowe B, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Co-chrane Database Syst Rev 2005; (1): CD004360
159. Schaeffer EM, Pohlman A, Morgan S, et al. Oxygenation in status asthmaticus improves during ventilation with helium-oxygen. Crit Care Med 1999; 27: 2666-2670
160. Venkataraman ST. Heliox during mechanical ventilation. Respir Care 2006; 51: 632-639
161. Burburan SM, Xisto DG, Rocco PR. Anaesthetic management in asthma. Minerva Anestesiol 2007; 73: 357-365
162. Mutlu GM, Factor P, Schwartz DE, et al. Severe status asthmaticus: management with permissive hypercapnia and inhalation anesthesia. Crit Care Med 2002; 30: 477-480
163. Restrepo RD, Pettignano R, DeMeuse P. Halothane, an effective infrequently used drug, in the treatment of pe-diatric status asthmaticus: a case report. J Asthma 2005; 42: 649-651
164. MacDonnell KF, Moon HS, Sekar TS, et al. Extracorporeal membrane oxygenator support in a case of severe status asthmaticus. Ann Thorac Surg 1981; 31: 171-175
165. Shapiro MB, Kleaveland AC, Bartlett RH. Extracorporeal life support for status asthmaticus. Chest 1993; 103: 1651-1654
166. Cooper DJ, Tuxen DV, Fischer MM. Extracorporeal life support for status asthmaticus. Chest 1994; 106: 978-979
167. Kukita I, Okamoto K, Sato T, et al. Emergency extracorporeal life support for patients with near fatal status asthmaticus. Am J Emerg Med 1997; 15: 566-569
168. Mikkelsen ME, Woo YJ, Sager JS, et al. Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus. ASAIO J 2009; 55: 47-52
169. Kuyper LM, Pare PD, Hogg JC, et al. Characterization of airway plugging in fatal asthma. Am J Med 2003; 115: 6-11
170. Barnes PJ. Future therapies. In: Barnes PJ, Drazen JM, Rennard SI, et al., editors. Asthma and COPD: basic mechanisms and clinical management. 2nd ed. Boston (MA): Academic Press, 2009: 737-747